Share |
Home > GMO Record > DIR

DIR 116 - Limited and Controlled Release Of Genetically Modified Live Viral Vaccines Against Prostate Cancer

DIR 116 - Notification of decision to issue a licence on application - posted 5 October 2012 (HTML)
DIR 116 - Notification of decision to issue a licence on application - posted 5 October 2012 (PDF 62 KB)
    DIR 116 - Questions and Answers (HTML)
    DIR 116 - Questions and Answers (PDF 9 KB)

    DIR 116 - Risk Assessment and Risk Management Plan (RARMP) Executive Summary (HTML)
    DIR 116 - Risk Assessment and Risk Management Plan (RARMP) Executive Summary (PDF 59 KB)

    DIR 116 - Risk Assessment and Risk Management Plan (RARMP) Technical Summary (HTML)
    DIR 116 - Risk Assessment and Risk Management Plan (RARMP) Technical Summary (PDF 85 KB)

    DIR 116 - Full Risk Assessment and Risk Management Plan (RARMP) for the limited and controlled release of genetically modified live viral vaccines against prostate cancer (HTML )
    DIR 116 - Full Risk Assessment and Risk Management Plan (RARMP) for the limited and controlled release of genetically modified live viral vaccines against prostate cancer (PDF 538 KB)

    DIR 116 - Licence Application Summary (HTML)
    DIR 116 - Licence Application Summary (PDF 170 KB)

    DIR 116 - GM Viral Vaccine Licence Conditions (HTML)
    DIR 116 - GM Viral Vaccine Licence Conditions (PDF 44 KB)


      Reference material

      Risk Analysis Framework for Licence Applications to the Office of the Gene Technology Regulator (3rd Edition) 2009